secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2026-07-02T20:30:31+00:00
Accession:  0001493152-26-031918
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Hepion Pharmaceuticals appoints Danina Fisher and Gary S. Stetz, II to board
----------------------------------------------------------------------------

- Danina Fisher and Gary S. Stetz, II appointed as directors effective July 1, 2026.
- Gary S. Stetz, II is the son of Gary Stetz, the Interim CEO.
- No arrangements or understandings with any other person regarding their selection as directors.
- No family relationships exist between the new directors except the father-son relationship noted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000149315226031918/0001493152-26-031918-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000149315226031918/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-031918

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer